Delivery Order SPE2DB24D2106-SPE2DB25FAVEU

Award Date 5/6/25
Potential Completion Date 5/28/25
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,135.35 firm fixed-price delivery order is for the supply of PROMACTA 25 MG TABLET 30S, a specialized pharmaceutical product. The contract has an ultimate completion date of December 24, 2024. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This federal contract award is a $4,417.24 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4567199030 - PROMACTA 12.5 MG TABLET UU 30S, a specialized pharmaceutical product, with a period of performance through February 28, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This federal contract award, valued at $4,418.06, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product "PROMACTA 25 MG TABLET UU 30S" and has a firm fixed-price pricing type with a completion date of May 6, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $21,727.74 contract is for the delivery of PROMACTA 50 MG TABLET, a branded pharmaceutical product, with a period of performance ending April 3, 2024. DMS Pharmaceutical Group holds a separate $4,999,999 indefinite-delivery, indefinite-quantity (IDIQ) contract with DLA to provide a broad range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,026.53, is for the delivery of PROMACTA 50 MG TABLET UU 30S, a prescription medication, to support the medical supply needs of military healthcare facilities. The contract has a completion date of February 19, 2025 and is not associated with any set-aside designation. DMS...
This is a delivery order award under contract SPE2DB24D2106 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $21,727.74 firm fixed-price contract is with the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including PROMACTA 50 mg tablets. This award is not associated with any set-aside program. DMS Pharmaceutical Group holds an indefinite delivery contract, SPE2DB24FATWX, with DLA valued up to $4,999,999 through 2025...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,000.32 firm fixed-price delivery order contract is for the provision of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This award is under DMS Pharmaceutical Group's larger $499,999,999...
The U.S. government's Defense Logistics Agency (DLA) has awarded a $1,294.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract, which has an ultimate completion date of August 29, 2024, is part of the DLA's Medical Supply Chain program and will have DMS Pharmaceutical Group provide a variety of pharmaceutical products, including branded and generic prescription drugs,...
This federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,770 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on April 28, 2021, with an ultimate completion date of April 29, 2021. The contract is part of the DLA's Medical Supply Chain division and provides a wide range of pharmaceutical products and medical supplies, including prescription drugs,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order (SPE2DX24FAFN1) under the larger SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999 with the Defense Logistics Agency (DLA). The contract is for the delivery of a variety of pharmaceutical products, including prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAVEU
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,418.06 firm fixed-price delivery order is for the supply of 4,568,160,321 units of the prescription drug Promacta 25 mg tablets. The contract has an ultimate completion date of May 28, 2025 and was awarded on May 6, 2025.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 8/10/25, 12:54 AM